Pricing
  1. US-listed companies
  2. Emergent BioSolutions Inc.
  3. Financials
  4. D/E ratio (%)

Emergent BioSolutions Inc. (EBS)

Market cap
$446.71M
P/E ratio
SummaryFinancials
Period EndD/E ratio (%) (Million USD)YoY (%)
Dec 31, 2024137.5+99.91%
Dec 31, 202368.8+112.05%
Dec 31, 202232.4-35.13%
Dec 31, 202150-13.98%
Dec 31, 202058.1-20.76%
Dec 31, 201973.3-6.68%
Dec 31, 201878.6+5212.09%
Dec 31, 20171.5-96.44%
Dec 31, 201641.6+11.24%
Dec 31, 201537.4+195.40%
Dec 31, 201312.7-10.81%
Dec 31, 201214.2-0.48%
Dec 31, 201114.3

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat